Results per Page:
Experts urge clinical trials network to study infectious disease therapies in immunocompromised patients
More than 6% of Americans are immunocompromised, yet most clinical trials exclude them
Cytomegalovirus has an activity shift following CAR T-cell therapy
From the Hill Group, Vaccine and Infectious Disease and Clinical Research Divisions